Dr. Etai Adam, MD Reviews

A 28-year-old Ethiopian refugee with aplastic anemia, no family matches, received a successful haploidentical transplant from her brother after Dr. Adam pioneered a novel conditioning regimen. She returned to her community health worker job within 9 months.

A 72-year-old retired engineer with myelodysplastic syndrome developed severe graft-versus-host disease post-transplant. Dr. Adam implemented an experimental mesenchymal stem cell infusion protocol, leading to complete resolution without impacting graft function.

A 7-year-old Bedouin girl with severe combined immunodeficiency received an unrelated cord blood transplant arranged by Dr. Adam. Her nomadic family stayed at the hospital's hospitality house throughout her 6-month recovery, learning sterile care techniques.

A 45-year-old ultra-Orthodox Jewish mother of eight with acute myeloid leukemia required fertility-preserving transplant protocols. Dr. Adam coordinated with reproductive specialists to harvest eggs pre-transplant, achieving both cure and future family preservation.

A 33-year-old professional athlete with relapsed Hodgkin's lymphoma underwent a reduced-intensity transplant. Dr. Adam designed a rehabilitation program that allowed return to competitive cycling within 14 months, now cancer-free.

An 18-year-old Arab university student with thalassemia major received a matched unrelated donor transplant after Dr. Adam secured funding through an international charity. Now studying medicine, inspired by his experience.

A 60-year-old Holocaust survivor with myelofibrosis, initially refusing treatment due to medical trauma, gradually trusted Dr. Adam's personalized approach. Successful transplant followed by psychological support integration.

A 5-year-old Ukrainian refugee with Wiskott-Aldrich syndrome received an emergency transplant during the conflict. Dr. Adam coordinated with international agencies for donor procurement and post-transplant housing for the displaced family.

A 38-year-old single father with chronic lymphocytic leukemia developed rare transplant complications. Dr. Adam's team created a home-care system allowing him to maintain custody of his young daughter during recovery.

A 52-year-old Palestinian teacher with multiple myeloma achieved complete remission after tandem autologous-allogeneic transplant. Dr. Adam facilitated cross-border follow-up care through telemedicine partnerships.

A 29-year-old LGBTQ+ activist with HIV-associated lymphoma received a specialized transplant protocol addressing both conditions. Dr. Adam collaborated with infectious disease specialists to develop this innovative approach.

A 65-year-old retired fisherman with amyloidosis underwent transplant with cardiac involvement. Dr. Adam's modified conditioning regimen prevented further heart damage, with full functional recovery after 18 months.

A 12-year-old with sickle cell disease from a low-income family received a successful sibling donor transplant. Dr. Adam's social work team secured long-term housing near the hospital for the family during treatment.

A 41-year-old software developer with myeloproliferative neoplasm participated in Dr. Adam's clinical trial using CRISPR-edited stem cells. Now disease-free and contributing to patient advocacy networks.

An 80-year-old Holocaust survivor with acute leukemia became Israel's oldest transplant recipient under Dr. Adam's care. Tailored minimal intensity protocol allowed return home to great-grandchildren within 5 months.